| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/06/1997 | EP0787135A1 Water-soluble epipodophyllotoxin derivatives, preparation method therefor, and use thereof as a drug and for treating cancer |
| 08/06/1997 | EP0787126A1 Bis-(2-haloethyl)aminophenyl substituted distamycin derivatives as antitumor and antiviral agents |
| 08/06/1997 | EP0787123A1 Inhibitors of farnesyl-protein transferase |
| 08/06/1997 | EP0787122A2 Calcium receptor-active compounds |
| 08/06/1997 | EP0787011A1 Pharmaceutical compositions |
| 08/06/1997 | EP0787009A1 Cancer inhibitory peptides |
| 08/06/1997 | EP0664819B1 Chelating polymers |
| 08/06/1997 | EP0585397B1 Bombesin analogs |
| 08/06/1997 | EP0577745B1 Bis-naphthalimides containing amide and thioamide linkers as anticancer agents |
| 08/06/1997 | EP0548070B1 Monoclonal antibody for differentiation of squamous cell carcinoma antigens and method of use for same |
| 08/06/1997 | CN1156447A 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceuticals |
| 08/06/1997 | CA2196909A1 Derivatives of 3-bromo- and 3, 3-dibromo-4-oxo-1-azetidines, processes for the preparation thereof and their use |
| 08/05/1997 | US5654449 Taxoids, their preparation and the pharmaceutical compositions which contain them |
| 08/05/1997 | US5654427 Protein kinase inhibitors |
| 08/05/1997 | US5654420 Reacting a reducing agent and a cyanolating agent with a 3',5'-(tetraalkyldisilox-1,3-diyl)cytosine, thymine or uracil derivative; antitumor agents |
| 08/05/1997 | US5654415 Antisense oligonucleotides to p53 |
| 08/05/1997 | US5654333 Methods for prevention of cancer using phenylacetic acids and derivatives thereof |
| 08/05/1997 | US5654331 Diaromatic compounds derived from a salicylic unit and their use in human and veterinary medicine and in cosmetics |
| 08/05/1997 | US5654328 Synergistic mixture of platinum compound with tellurium or selenium compound as antitumor or anticarcinogenic agents |
| 08/05/1997 | US5654307 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 08/05/1997 | US5654304 Chemosensitizing agents; cancer therapy; drug resistance |
| 08/05/1997 | US5654286 Applying to skin 2-chlorodeoxyadenosine-5'-monophosphate or salt |
| 08/05/1997 | US5654282 Antiinflammatory agents; viricides; anticancer agents |
| 08/05/1997 | US5654279 Tissue destruction in cryosurgery by use of thermal hysteresis |
| 08/05/1997 | US5654277 Inhibiting tumor metastasis in mammals by administering specific tetra- or pentapeptides |
| 08/05/1997 | US5653981 Use of nigella sativa to increase immune function |
| 08/05/1997 | CA1339221C Polyhydroxybenzoic acid derivatives |
| 08/05/1997 | CA1339220C Fatty acid analog enzyme substrates |
| 08/05/1997 | CA1339217C 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents |
| 08/05/1997 | CA1339204C Mucin core polypeptide, antibodies and probes |
| 08/05/1997 | CA1339199C Magnetic protein conjugates, a process for the preparation thereof, and the use thereof |
| 08/05/1997 | CA1339198C Antibodies to the antigen campath-1 |
| 07/31/1997 | WO1997027297A1 Inhibitors of cell-cycle progression, and uses related thereto |
| 07/31/1997 | WO1997027286A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 07/31/1997 | WO1997027208A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 07/31/1997 | WO1997027206A1 Oligonucleotide analogs |
| 07/31/1997 | WO1997027202A1 Terpyridine-platinum(ii) complexes |
| 07/31/1997 | WO1997027199A1 Pyrrolopyrimidines and processes for their preparation |
| 07/31/1997 | WO1997027174A1 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 07/31/1997 | WO1997026918A2 Ligand directed enzyme prodrug therapy |
| 07/31/1997 | WO1997026915A1 Use of a thexaphyrin in the preparation of a medicament for use with a chemotherapeutic agent in cancer chemosensitization |
| 07/31/1997 | WO1997026903A1 Microencapsulated genetically engineered microorganisms for clinical application |
| 07/31/1997 | WO1997026881A1 Method for inducing death of neoplastic cells using piperazine oxirane derivatives |
| 07/31/1997 | WO1997026878A1 Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) |
| 07/31/1997 | WO1997026877A1 Methods of inhibiting colon tumors |
| 07/31/1997 | WO1997026867A2 Solid instant-release forms of administration and process for producing the same |
| 07/31/1997 | WO1997022360A3 Control of protein synthesis, and screening method for agents |
| 07/31/1997 | WO1997015269A3 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 07/31/1997 | DE19602757A1 Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung Fixed instant release dosage forms and methods for their preparation |
| 07/31/1997 | CA2244693A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 07/31/1997 | CA2244373A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 07/31/1997 | CA2243964A1 Solid instant-release forms of administration and processes for their production |
| 07/31/1997 | CA2242960A1 Inhibitors of cell-cycle progression, and uses related thereto |
| 07/31/1997 | CA2242657A1 Method for inducing death of neoplastic cells using piperazine oxirane derivatives |
| 07/31/1997 | CA2241992A1 Terpyridine-platinum(ii) complexes |
| 07/30/1997 | EP0786253A1 Agent for suppressing tumour growth |
| 07/30/1997 | EP0786002A1 Intracellular isoform of the interleukin-1 receptor antagonist |
| 07/30/1997 | EP0785951A1 Tc or re radiolabelled somatostatin analogs |
| 07/30/1997 | EP0785945A1 New peptides with immunomodulatory effects |
| 07/30/1997 | EP0785938A1 Fused pyrrolocarbazoles |
| 07/30/1997 | EP0785792A1 Treatment of ovarian estrogen dependent conditions |
| 07/30/1997 | EP0785784A1 4-heterocyclic piperidines promote release of growth hormone |
| 07/30/1997 | EP0668866B1 Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides |
| 07/30/1997 | EP0636146B1 Tachykinin antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds |
| 07/30/1997 | CN1155838A Indolinone compounds for the treatment of disease |
| 07/30/1997 | CN1155538A Substituted imidogen sulfamide, its preparation, use and medicines containing the same |
| 07/29/1997 | US5652367 Halo-nitro-isoquinolinone compounds and pharmaceutical compositions thereof |
| 07/29/1997 | US5652355 Hybrid oligonucleotide phosphorothioates |
| 07/29/1997 | US5652353 DNAs encoding tumor necrosis factor-α muteins |
| 07/29/1997 | US5652254 Treatment of degenerative diseases, rheumatoid arthritis, psoriasis, cystic fibrosis |
| 07/29/1997 | US5652250 N-substituted β-aryl- and β-heteroaryl-α-cyanoacrylamide derivatives and process for their preparation |
| 07/29/1997 | US5652243 Modulating cellular response |
| 07/29/1997 | US5652234 3-(7-oxo-1-aza-4-oxabicyclo[3.2.0]hept-3-yl)alanine derivative as antitumor agent |
| 07/29/1997 | US5652227 Inhibition of the degradation of connective tissue matrix protein components in mammals |
| 07/29/1997 | US5652223 DNA encoding CAI resistance proteins and uses thereof |
| 07/29/1997 | US5652210 Soluble splice variant of the Fas (APO-1) antigen, FasΔTM |
| 07/29/1997 | US5652130 Retroviral vectors expressing tumor necrosis factor (TNF) |
| 07/29/1997 | US5652105 Substrate for detection of mammalian 5-C-DNA methyltransferase |
| 07/29/1997 | US5652095 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 07/29/1997 | US5651989 Iron/carbon particles for drug delivery, using an external magnetic field to direct drug to target area inside body |
| 07/29/1997 | US5651964 Transfection, gene expression, antitumor, anticarcinogenic |
| 07/29/1997 | CA1339134C (2s)-(5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b] pyrazin-7-yl) carbamic acid, ethyl ester |
| 07/29/1997 | CA1339096C Novel one step method and polynucleotide compounds for hybridizing to target polynucleotides |
| 07/29/1997 | CA1339077C Liposome-encapsulated vinca alkaloids and their use in combatting tumors |
| 07/24/1997 | WO1997026535A1 Isolated tyrosinase derived peptides and uses thereof |
| 07/24/1997 | WO1997026523A2 Detection of a leptin receptor variant and methods for regulating obesity |
| 07/24/1997 | WO1997026370A1 Leptin receptor variants |
| 07/24/1997 | WO1997026346A1 NOVEL TRYPTOPHANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026328A1 Immunotherapy using cytotoxic t lymphocytes (ctl) |
| 07/24/1997 | WO1997026272A1 Leptin receptor variants |
| 07/24/1997 | WO1997026253A1 Novel benzoyl guanidine derivatives, process for their preparation and their use in the preparation of medicines |
| 07/24/1997 | WO1997026237A1 Aromatic polycyclic retinoid-type derivatives, method for preparing same, and use thereof for making pharmaceutical and cosmetic compositions |
| 07/24/1997 | WO1997026017A2 Perfluoroalkyl-containing metal complexes and their use in nmr diagnostics |
| 07/24/1997 | WO1997025977A1 Pharmaceutical compositions |
| 07/24/1997 | WO1997025860A1 Cellular immunogens useful as cancer vaccines |
| 07/24/1997 | WO1997014808A3 Herpesvirus vectors and their uses |
| 07/24/1997 | WO1997007198A3 Dna sequences and secreted proteins encoded thereby |
| 07/24/1997 | DE19603033A1 Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik Perfluoroalkyl-containing metal complexes, processes for their preparation and their use in NMR diagnosis |
| 07/24/1997 | CA2678707A1 Pharmaceutical compositions comprising ascomycin derivatives |
| 07/24/1997 | CA2243295A1 Aromatic polycyclic retinoid-type derivatives, method for preparing same, and use thereof for making pharmaceutical and cosmetic compositions |